Duke Team Says Sequencing May be Better than GWAS at Pinpointing Disease-Causing Variants
April 05, 2011
Duke Team Says Sequencing May be Better than GWAS at Pinpointing Disease-Causing Variants
Duke researchers sequenced the whole genomes of 29 individuals and found that rare variants are more likely than common ones to fall in functional regions of the genome.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Sequencing Genes Implicated in GWAS Uncovers Rare Variants in Disease Cohort
July 27, 2010 / In Sequence - New Products: Swift Biosciences' Accel-NGS Kit; Roche/Hamilton's Automated DNA Enrichment; More
March 5, 2013 / In Sequence - People in the News: Matt Posard, Martin Tolar, Jonas Lee, Marc Rubenfield, David Goldstein
January 11, 2012 / Clinical Sequencing News - Paired Ends: Marc Stapley, Stan Rose, Michael Hunkapiller, Jeffrey Sklar, Martin Tolar
January 10, 2012 / In Sequence - Swedish Project Will Sequence Tumor Exomes to Study Drug Resistance, Develop Companion Tests
August 31, 2011 / Clinical Sequencing News